Skin conditions (dermatitis, eczema, psoriasis) decisions — 2025

The Board remands the claims for a new VA examination to obtain a detailed assessment of the current severity of the Veteran's pseudofolliculitis barbae with dyschromia, as the previous examination was inadequate.

The Board denied a compensable rating for acne, granted a 10 percent rating for asthma, and denied ratings greater than 10 percent for tinnitus, traumatic dislocation of septal cartilage, left wrist tendonitis, right knee patellofemoral pain syndrome and degenerative joint disease, and left ring finger and palm surgical scarring. The Board also granted a 10 percent rating for left ring finger status post DIP arthrodesis and nodule excision.

The Board remanded the Veteran's claims for service connection of right and left knee disabilities as secondary to a service-connected back condition, and for increased ratings for dermatitis. The Board needs more information from VA examinations.

The Board granted service connection for the veteran's eczema, finding that it is related to his military service.

The Board remands the claim for a retrospective medical opinion on whether the topical corticosteroid treatments used prior to November 22, 2017, are considered systemic therapy.

The appeal was denied for higher ratings and remanded for service connection of various conditions.

The Board dismissed the claims for service connection for bilateral hearing loss and tinnitus, denied service connection for a respiratory condition, and remanded the claim for dermatitis.

The Board denied the Veteran's appeal for a total disability due to individual unemployability based on a single disability for special monthly compensation purposes, as there was no evidence that any single service-connected condition or combination of conditions rendered him unable to obtain and maintain gainful employment.

The appeal for initial compensable disability ratings for irritable bowel syndrome and pseudofolliculitis barbae was withdrawn by the Veteran.

The Board denied a compensable rating for pseudofolliculitis barbae and remanded the claim for service connection for erectile dysfunction.

The veteran's appeal for service connection for pseudofolliculitis barbae was dismissed because the veteran withdrew the claim.

The veteran's claim for a compensable rating for hemorrhoids was denied, but the claim for TDIU from December 15, 2020 to September 1, 2022 was granted.

The Board denied the veteran's claims for higher ratings for neurodermatitis and tinea versicolor, stating that the evidence did not support a finding of more severe symptoms.

The veteran's claim for service connection for tinnitus was granted. The claim for a low back condition was denied. The claims for bilateral knee condition and tinea pedis were remanded for further development.

The veteran's claims for service connection for bilateral hearing loss, tinnitus, and psoriatic arthritis were granted. The claims for an acquired psychiatric disorder other than PTSD (including anxiety) and plaxis psoriasis were remanded.

The Veteran's gastroesophageal reflux disease (GERD) is granted an initial rating of 60 percent, while his pseudofolliculitis barbae (PFB) is denied a compensable rating.

The Board denied the Veteran's claim for an initial compensable disability rating for onychomycosis and tinea pedis as the condition affected less than 5 percent of his total body area and was treated with topical medication.

The Board denied the Veteran's claim for an initial compensable rating for pseudofolliculitis barbae as the evidence did not support a higher rating.

The Board granted service connection for pseudofolliculitis barbae based on the evidence showing its onset during active duty and continuity of symptoms since then.

The Board denied a compensable disability rating for pseudofolliculitis barbae and remanded the claims for service connection for back condition, allergic rhinitis, migraines, skin condition, bilateral eye condition, and an acquired psychiatric condition.